Literature DB >> 7633401

Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification.

H Caron1, M Peter, P van Sluis, F Speleman, J de Kraker, G Laureys, J Michon, L Brugières, P A Voûte, A Westerveld.   

Abstract

Previous reports on possible genomic imprinting of the neuroblastoma tumour suppressor gene on chromosome 1p36 have been conflicting. Here we report on the parental origin of 1p36 alleles lost in 47 neuroblastomas and on a detailed Southern blot analysis of the extent of the 1p deletions in 38 cases. The results are remarkably different for tumours with and without N-myc amplification. In the N-myc single copy tumours we show that the lost 1p36 alleles are of preferential maternal origin (16 of 17 cases) and that the commonly deleted region maps to 1p36.2-3. In contrast, all N-myc amplified neuroblastomas have larger 1p deletions, extending from the telomere to at least 1p35-36.1. These deletions are of random parental origin (18 of 30 maternal LOH). This strongly suggests that different suppressor genes on 1p are inactivated in these two types of neuroblastoma. Deletion of a more proximal suppressor gene is associated with N-myc amplification, while a distal, probably imprinted, suppressor can be deleted in N-myc single copy cases.

Entities:  

Mesh:

Year:  1995        PMID: 7633401     DOI: 10.1093/hmg/4.4.535

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  29 in total

1.  Unequal expression of allelic kainate receptor GluR7 mRNAs in human brains.

Authors:  H H Schiffer; G T Swanson; E Masliah; S F Heinemann
Journal:  J Neurosci       Date:  2000-12-15       Impact factor: 6.167

2.  Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines.

Authors:  X T Kong; V A Valentine; S T Rowe; M B Valentine; S T Ragsdale; B G Jones; D A Wilkinson; G M Brodeur; S L Cohn; A T Look
Journal:  Neoplasia       Date:  1999-04       Impact factor: 5.715

Review 3.  Clinical categories of neuroblastoma are associated with different patterns of loss of heterozygosity on chromosome arm 1p.

Authors:  J Mora; N K Cheung; B H Kushner; M P LaQuaglia; K Kramer; M Fazzari; G Heller; L Chen; W L Gerald
Journal:  J Mol Diagn       Date:  2000-02       Impact factor: 5.568

4.  Disseminated neuroblastomas under 1 year of age: cell biology and prognosis.

Authors:  F Lampert; H Christiansen; F Berner; H J Terpe; F Berthold
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

5.  Duplication of a genomic region containing the Cdc2L1-2 and MMP21-22 genes on human chromosome 1p36.3 and their linkage to D1Z2.

Authors:  R Gururajan; J M Lahti; J Grenet; J Easton; I Gruber; P F Ambros; V J Kidd
Journal:  Genome Res       Date:  1998-09       Impact factor: 9.043

6.  Aberrant methylation in cancer.

Authors:  R Versteeg
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

7.  Expression of SMARCF1, a truncated form of SWI1, in neuroblastoma.

Authors:  T Takeuchi; S Nicole; A Misaki; M Furihata; J Iwata; H Sonobe; Y Ohtsuki
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

8.  Allelic loss of the short arm of chromosome 4 in neuroblastoma suggests a novel tumour suppressor gene locus.

Authors:  H Caron; P van Sluis; R Buschman; R Pereira do Tanque; P Maes; L Beks; J de Kraker; P A Voûte; G Vergnaud; A Westerveld; R Slater; R Versteeg
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

9.  Co-expression of neighboring genes in the zebrafish (Danio rerio) genome.

Authors:  Huai-Kuang Tsai; Pei-Ying Huang; Cheng-Yan Kao; Daryi Wang
Journal:  Int J Mol Sci       Date:  2009-08-21       Impact factor: 6.208

10.  A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours.

Authors:  C Krona; K Ejeskär; H Carén; F Abel; R-M Sjöberg; T Martinsson
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.